Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran – a clinical case and global pharmacovigilance data

Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran – a clinical case and global pharmacovigilance data

We report the occurrence of immune thrombocytopenia (ITP) in a 77-year-old man a few days after receiving the first dose of the COVID-19 mRNA vaccine tozinameran (Comirnaty®). The patient was treated with systemic corticosteroids, intravenous immunoglobulins and eltrombopag. He elected to proceed...

Full description

Bibliographic Details
Main Authors: Raphael Battegay, Ioanna Istampoulouoglou, Andreas Holbro, Andreas Buser, Julia R. Hirsiger, Jens Eckstein, Christoph T. Berger, Sarah Koechlin, Anne B. Leuppi-Taegtmeyer
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2021-12-01
Series:Swiss Medical Weekly
Online Access:https://www.smw.ch/index.php/smw/article/view/3118

Internet

https://www.smw.ch/index.php/smw/article/view/3118

Similar Items